Paradoxical Arthralgia Secondary to Anti-Tumor-Necrosis-Factor Alpha Therapy in Crohn’s Disease

The current treatment of choice for polyarthralgia in Crohn’s disease consists of disease-modifying agents and anti-inflammatory therapy, such as anti-tumor-necrosis-factor alpha inhibitors like infliximab. However, here we report the case of a patient with longstanding Crohn’s disease, who develope...

Descripción completa

Detalles Bibliográficos
Autores principales: Thurlapati, Aswani, Gandu, Siva Santosh Kumar, Kulkarni, Shreedhar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301290/
https://www.ncbi.nlm.nih.gov/pubmed/34327073
http://dx.doi.org/10.7759/cureus.15835

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301290/
https://www.ncbi.nlm.nih.gov/pubmed/34327073
http://dx.doi.org/10.7759/cureus.15835

Ejemplares similares